Stem cell therapy in pulmonary hypertension: current practice and future opportunities
Pulmonary hypertension (PH) is a progressive disease characterised by elevated pulmonary arterial pressure and right-sided heart failure. While conventional drug therapies, including prostacyclin analogues, endothelin receptor antagonists and phosphodiesterase type 5 inhibitors, have been shown to i...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2023-09-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/32/169/230112.full |